Cold Pain Therapy Market: By Product (Gels, Sprays, Patches, Cold Packs, Wraps, Pads, Roll-Ons), by Therapy (Icepack Therapy, Chamber Therapy, Cryosurgery), by Application (Musculoskeletal Disorders, Post-Operative Therapy, Sports Medicine, Post-Trauma Therapy), by End-Users (Hospitals and Clinics, Sports Person, Adults Others), and Geography - Cold Pain Therapy Market Report Description

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Cold Pain Therapy Market size was valued at USD 2,628.1 million in 2022 and is projected to grow at a 5.7% CAGR over 2023 to 2029. Cold therapy is also known as cryotherapy. It works by reducing blood flow to a particular area, which can significantly reduce inflammation and swelling that causes pain, especially around a joint or a tendon. It can temporarily reduce nerve activity, which can also relieve pain. The Sprays segment anticipated to grow at significant CAGR over the forecast years. The epidermal layer of the skin at the site of inflammation or pain is treated with topical painkillers sprays. Topical pain relievers spray work primarily at the targeted site and in the central nervous system by administering drugs through the skin to the affected area. These Formulations are anaesthetic or analgesic medications that are applied directly to the painful area or close by. The aim is to offer a slow and gradual release of pain relief medication into the bloodstream by keeping the blood levels relatively constant for a certain period. Furthermore, the market players are focusing on launching and aquation of new product into the market to maintain the growth in the forecasting market. For instance, In August 2018 Sun Pharma launches pain relief spray Volini Maxx. Increasing number of hip and knee surgeries, increasing adoption of analgesic patches, growing number of injuries sustained while participating in athletics and gym exercises are a few factors driving the industry's growth over the forecasting period.

Cold Pain Therapy Market Key Developments:
In June 2021, Hisamitsu Pharmaceutical CO., Inc. (Japan) launched Air Salonpas Z, an analgesic and anti-inflammatory spray for muscle pain, bruises, and sprains, among other conditions.
In November 2020, Beiersdorf AG (Germany) invested USD 72.9 million (EUR 60 million) in Hamburg to develop technological centers for strengthening its R&D unit.

Cold Pain Therapy Market Summary

Study Period

2023– 29

Base Year




Largest Market

North America

Fastest Growing Market

North America
Cold Pain Therapy Market Dynamics

The usage of cold pain treatment also has the additional benefit of temporarily decreasing nerve signals, which lessens pain. The main factors propelling the expansion of the cold pain therapy market are the rising number of injuries incurred when engaging in sports and gym workouts, as well as the rising health care expenditures associated with injuries sustained while participating in sports activity. Market expansion, nevertheless, may be limited by issues such as a shortage of remuneration, a shortage of clinical indications for the drug for cold pain treatment, as well as the misery related to the treatment, among others.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Cold Pain Therapy Market Segmentation

By Application
  • Musculoskeletal Disorders
  • Post-operative Therapy
  • Sports Injuries
  • Post-trauma Therapy
By Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • E- Pharmacies
By Geography
  • North America
  • Europe
  • The Asia Pacific

Frequently Asked Questions

The cold pain therapy market is projected to expand at a CAGR of 5.7% during the forecast period

DJO Global, Inc. (US), Hisamitsu Pharmaceutical Co., Inc. (Japan), Össur (Iceland), Johnson & Johnson (US), Pfizer (US), Sanofi (France), Rohto Pharmaceutical (Japan)

North America is the fastest-growing region for cold pain therapy market

  • Beiersdorf AG (Germany)
  • DJO Global, Inc. (US)
  • Hisamitsu Pharmaceutical Co., Inc. (Japan)
  • Össur (Iceland)
  • Johnson & Johnson (US)
  • Pfizer (US)
  • Sanofi (France)
  • Rohto Pharmaceutical (Japan)
  • 3M (US)
  • Cardinal Health Inc. (US)
  • Bird & Cronin (US)